N-Difluoroacetylhexosamine as a Substrate-Engineering Precursor for Glycosylation Reactions

Area of Science:

• Carbohydrate Chemistry
• Chemical Biology
• Medicinal Chemistry

Background:

• Oligosaccharide synthesis is crucial for developing therapeutics and understanding biological processes.
• Conventional protecting groups for glucosamine can limit substrate compatibility and stability in synthetic routes.
• Developing efficient and robust methods for synthesizing structurally defined polysaccharides remains a challenge.

Purpose of the Study:

• To introduce and evaluate N-difluoroacetylglucosamine (GlcNDFA) as a novel precursor in oligosaccharide synthesis.
• To assess the advantages of GlcNDFA over conventional protecting groups like N-trifluoroacetylglucosamine.
• To demonstrate the application of GlcNDFA in a multi-step synthesis of a complex, biologically relevant polysaccharide.

Main Methods:

• Development of a chemical evolution strategy employing GlcNDFA for oligosaccharide assembly.
• Comparative analysis of GlcNDFA and N-trifluoroacetylglucosamine regarding substrate compatibility and stability.
• A 16-step synthesis pathway was established to produce dekaparin using GlcNDFA.

Main Results:

• GlcNDFA demonstrated enhanced substrate compatibility with glycosyltransferases compared to N-trifluoroacetylglucosamine.
• GlcNDFA exhibited improved stability in aqueous environments, facilitating its use in synthetic procedures.
• The 16-step synthesis yielded homogeneous dekaparin, a heparin-like medication, with a notable 62.2% yield.

Conclusions:

• N-difluoroacetylglucosamine (GlcNDFA) is a highly effective precursor for chemical evolution strategies in oligosaccharide synthesis.
• The superior properties of GlcNDFA enable precise and efficient construction of complex, structurally defined polysaccharides.
• This approach holds significant potential for the scalable production of therapeutic polysaccharides like dekaparin.